신규 인슐린 제제 및 전달 기술 시장 : 시린지 및 바이알에 대한 초점

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

The global market for insulin syringes and vials is expected to grow from $24.3 billion in 2023 and projected to reach $37.0 billion by the end of 2028, at a CAGR of 8.7% from 2023 through 2028.

The global market for smart insulin pens is expected to grow from $4.2 billion in 2023 and projected to reach $7.7 billion by the end of 2028, at a CAGR of 12.6% from 2023 through 2028.

Report Scope:

This report discusses the implications of the growing diabetes epidemic on the global and regional markets for emerging insulin drug and delivery technologies. It discusses companies in the relevant pharmaceutical and medical industries and provides profiles of the leading players as well as an update on M&A activity. The report's patent analysis focuses on developments in Japan, Europe and the U.S. Five-year global sales forecasts are provided for the major categories of insulin drug and delivery technologies and devices categories.

This report segments the global market into four regions -

• North America.
• Europe.
• Asia-Pacific.
• Rest of the World (RoW).

Report Includes:

• 57 data tables and 83 additional tables
• An overview and industry analysis of the global markets for emerging insulin drug and delivery technologies, with an emphasis on plastic insulin syringes and vials
• Analyses of the global market trends, with historical market revenue data (sales figures) for 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
• Estimate of the actual market size and revenue growth forecast, and a corresponding market share analysis by product type, application and region
• A look at the emerging technologies that have potential in the diabetes market, with improved glucose control, along with improved delivery methods
• Examination of the current state of the insulin drug and delivery industry structure, focusing on technological updates and issues surrounding insulin pens and insulin syringes, ongoing research activities, and regulatory and pricing scenarios
• Discussion of market dynamics, clinical trial applications, regulations, and penetration of technologies in the pharmaceutical and biotechnology markets
• Discussion of the ESG developments and how they impact corporate performance, ratings and matrices and consumer attitude, as well as the ESG practices of leading pharma and biotech companies
• Review of the key patent grants/publications for insulin as a drug, along with its delivery methods
• Analysis of the competitive landscape based on recent developments and segmental revenues of leading companies
• Profiles of the leading market players

Table of Contents

Chapter 1 Introduction

• Overview
• Study Goals and Objectives
• Reasons for Doing the Study
• What's New in this Report?
• Scope of Report
• Information Sources
• Methodology
• Secondary Research
• Geographic Breakdown
• Segmentation Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Summary
• Developments and Trends

Chapter 3 Market Overview

• Introduction
• What is Diabetes?
• Types of Diabetes
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes Mellitus or Hyperglycemia in Pregnancy
• Impaired Glucose Tolerance and Impaired Fasting Glucose
• Epidemiology of Diabetes
• Gender Distribution
• Regional Disparities
• Market Dynamics Snapshot
• Factors Affecting the Market
• Market Drivers
• Market Restraints

Chapter 4 Global Market for Emerging Insulin Drug and Delivery Technologies, by Type

• Overview
• Technological Advances in Insulin Syringes
• Insulin Delivery Pen Devices
• Disposable Insulin Pens
• Reusable Insulin Pens
• Technological Advances in Insulin Drug and Delivery Pen Devices
• External Insulin Pumps
• Technological Advances in Insulin Pump Systems
• Implantable Insulin Pumps
• Closed-Loop Artificial Pancreas
• Bionic Pancreas
• Smart Pens

Chapter 5 Global Market for Emerging Insulin Drug Delivery Devices, by Application

• Overview
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes

Chapter 6 Global Market for for Insulin Drug Delivery Devices, by Region

• Overview
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Regulatory Landscape

• Overview
• U.S. Regulations for Insulin Drug and Delivery Technologies
• European Regulations for Insulin Drug and Delivery Technologies
• Japan's Regulations for Insulin Drug and Delivery Technologies
• China's Regulations for Insulin Drug and Delivery Technologies

Chapter 8 Sustainability in the Insulin Drug and Delivery Market: An ESG Perspective

• Introduction
• ESG Performance Analysis

Chapter 9 Emerging Technologies

• Introduction
• Patient Outcomes Beyond Glucose Control

Chapter 10 Patent Analysis

• Overview

Chapter 11 M&A and Venture Funding Outlook

• M&A Analysis

Chapter 12 Competitive Landscape

• Overview

Chapter 13 Company Profiles

• ASTRAZENECA
• B. BRAUN SE
• BD
• CARDINAL HEALTH
• DEBIOTECH SA
• DIABELOOP SA
• EMPERRA GMBH E-HEALTH TECHNOLOGIES
• EMBECTA CORP.
• F. HOFFMANN-LA ROCHE LTD.
• INSULET CORP.
• JOHNSON & JOHNSON SERVICES INC.
• LIFESCAN IP HOLDINGS LLC.
• LILLY
• MEDTRONIC
• NOVO NORDISK A/S
• NUGEN MEDICAL DEVICES
• OWEN MUMFORD LTD.
• SANOFI
• SOOIL DEVELOPMENTS CO. LTD.
• TANDEM DIABETES CARE INC.
• TERUMO CORP.
• YPSOMED AG

Chapter 14 Appendix

• Government Regulatory Agencies and Professional Organizations
• List of References